Breaking News Instant updates and real-time market news.

AAPL

Apple

$225.65

8.08 (3.71%)

07:30
09/12/19
09/12
07:30
09/12/19
07:30

August China shipments dip ahead of Apple iPhone 11 launch, says Credit Suisse

Credit Suisse analyst Matthew Cabral says that Apple iPhone shipments in China fell 19.5% year over year in the month of August per MIIT "non-Android" data, worse than the 2.8% year over year drop in the broader Chinese smartphone market. But looking quarter-to-date, Q3 is up 5.2% year over year, which is a significant improvement versus the difficult start to the year and is tracking well toward Apple's above seasonal September guidance, he contends. The analyst believes the introduction of a triple-camera system on the Pro/Pro Max and the RMB700 price cut should help demand within China at the margin. However, Cabral views this year's feature upgrades as more incremental in nature and thinks they are unlikely to reverse the ongoing extension of replacement cycles, especially without a 5G iPhone until the second half of 2020. He reiterates a Neutral rating and $209 price target.

AAPL Apple
$225.65

8.08 (3.71%)

09/11/19
FBCO
09/11/19
NO CHANGE
FBCO
Netflix head start unlikely dented by Apple TV+, says Credit Suisse
Credit Suisse analyst Douglas Mitchelson notes that his Netflix (NFLX) thesis already presumes increased competition in the future and Apple (AAPL) is noteworthy as it certainly has a "terrific brand and global distribution platform." However, the analyst believes Netflix's 10-year head start, scale, breath of content and customer engagement is unlikely to be dented by an Apple TV+ subscription service with a relatively light content slate and no library content. In fact, Apple TV+ looks more like an HBO (T) or Showtime than a Netflix, Hulu or Amazon Prime (AMZN), he contends, adding that he continues to believe SVOD will not be a zero sum game. Lastly, Mitchelson would expect Apple TV+ would more likely displace a runner-up than the leader.
09/11/19
MAXM
09/11/19
NO CHANGE
Target $204
MAXM
Hold
Apple price target lowered to $204 from $211 at Maxim
Maxim analyst Nehal Chokshi lowered his price target on Apple to $204 after its Special Event presentation, saying the company's announcements of new iPhones and Watch models were all in-line with expectations. The analyst also states that the Apple TV+ subscription terms were 2-times lowers than his estimate and should weigh on Apple's gross margins. Chokshi keeps his Hold rating on Apple.
09/11/19
JPMS
09/11/19
NO CHANGE
JPMS
Overweight
Apple TV+ pricing a positive catalyst for adoption, says JPMorgan
JPMorgan analyst Samik Chatterjee came out of Apple's (AAPL) event yesterday "largely positive," believing lowered pricing of the iPhone 11 relative to the XR could act as a positive driver for volumes in the entry level premium smartphone segment. Further, the analyst says "favorable pricing" for Apple TV+ and Apple Arcade makes him positive on the potential ramp of the new services. Apple TV+'s monthly subscription price of $4.99 is "quite attractive" relative to competitive services, which should be a positive catalyst for adoption as Apple scales up its original content over time to compete with Netflix (NFLX), Amazon's (AMZN) Prime Video and Disney (DIS), among others, Chatterjee told investors earlier in a research note. He kept an Overweight rating on Apple shares.
09/12/19
IMPC
09/12/19
NO CHANGE
Target $451
IMPC
Outperform
Apple TV pricing adds pressure to Netflix and Disney, says Imperial Capital
The $4.99 monthly price of Apple's (AAPL) TV+ adds pressure to both Netflix (NFLX) and Disney (DIS), Imperial Capital analyst David Miller tells investors in a research note. The price point took most analysts by surprise, as $4.99 is "far less" than what had been previously estimated going in to Apple's presentation, which was somewhere around the $9.00 level, according to Miller. In addition, while Apple's content lineup is not nearly as robust as that offered currently by Netflix , or what will be offered by Disney+, its lineup looked "fairly impressive," headlined by talent such as Jennifer Aniston, Samuel L. Jackson, Ron Moore, Aaron Paul, Oprah Winfrey, Octavia Spencer, and M. Night Shyamalan, Miller contends. However, he believes the market is too focused on price points rather than the "value" for that said price point. The analyst keeps an Outperform rating on Netflix shares with a $451 price target.

TODAY'S FREE FLY STORIES

XGN

Exagen

$12.18

-1.17 (-8.76%)

09:00
10/14/19
10/14
09:00
10/14/19
09:00
Initiation
Exagen initiated  »

Exagen initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOOP

Loop Industries

$10.39

0.01 (0.10%)

08:56
10/14/19
10/14
08:56
10/14/19
08:56
Initiation
Loop Industries initiated  »

Loop Industries initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$16.08

-2.56 (-13.73%)

08:55
10/14/19
10/14
08:55
10/14/19
08:55
Recommendations
Jeld-Wen analyst commentary  »

Jeld-Wen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

AAPL

Apple

$236.21

6.12 (2.66%)

, BAC

Bank of America

$28.90

0.46 (1.62%)

08:55
10/14/19
10/14
08:55
10/14/19
08:55
Options
Notable open interest changes for October 14th »

Friday's total…

AAPL

Apple

$236.21

6.12 (2.66%)

BAC

Bank of America

$28.90

0.46 (1.62%)

FB

Facebook

$184.20

4.02 (2.23%)

TSLA

Tesla

$247.84

3.14 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 30

    Oct

  • 12

    Nov

ZG

Zillow

$29.25

0.52 (1.81%)

08:50
10/14/19
10/14
08:50
10/14/19
08:50
Recommendations
Zillow analyst commentary  »

Zillow's Flex, PA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

EV

Eaton Vance

$43.47

0.875 (2.05%)

08:50
10/14/19
10/14
08:50
10/14/19
08:50
Hot Stocks
Eaton Vance reports consolidated AUM $489.7B on September 30 »

This compares to $482.8B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

FLXN

Flexion

$13.37

0.125 (0.94%)

08:47
10/14/19
10/14
08:47
10/14/19
08:47
Recommendations
Flexion analyst commentary  »

Benchmark still sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACB

Aurora Cannabis

$3.68

-0.045 (-1.21%)

, USAT

USA Technologies

$0.00

(0.00%)

08:45
10/14/19
10/14
08:45
10/14/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

ACB

Aurora Cannabis

$3.68

-0.045 (-1.21%)

USAT

USA Technologies

$0.00

(0.00%)

BYND

Beyond Meat

$131.40

-4.6 (-3.38%)

CGC

Canopy Growth

$19.42

-1.005 (-4.92%)

CHK

Chesapeake

$1.38

0.09 (6.98%)

PZZA

Papa John's

$53.16

0.32 (0.61%)

NVAX

Novavax

$4.57

0.11 (2.47%)

DXJ

WisdomTree Japan Hedged Equity Fund

$51.12

1.1 (2.20%)

PTON

Peloton

$22.40

-0.755 (-3.26%)

UBER

Uber

$30.09

1.19 (4.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 04

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 19

    Nov

NFLX

Netflix

$282.89

2.47 (0.88%)

08:42
10/14/19
10/14
08:42
10/14/19
08:42
Recommendations
Netflix analyst commentary  »

RBC Capital sees Q3 …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 29

    Oct

AKTX

Akari Therapeutics

$1.81

-0.03 (-1.63%)

08:42
10/14/19
10/14
08:42
10/14/19
08:42
Hot Stocks
Akari Therapeutics announces new data from ongoing Phase I/II AKC trial »

Akari Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:41
10/14/19
10/14
08:41
10/14/19
08:41
Hot Stocks
Parsley Energy sees Jagged Peak Energy deal immediately accretive on key metrics »

Key Transaction…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

NVST

Envista

$27.87

-1.2 (-4.13%)

08:40
10/14/19
10/14
08:40
10/14/19
08:40
Initiation
Envista initiated  »

Envista initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVST

Envista

$27.87

-1.2 (-4.13%)

, DHR

Danaher

$138.78

0.1 (0.07%)

08:38
10/14/19
10/14
08:38
10/14/19
08:38
Initiation
Envista, Danaher initiated  »

Envista initiated with an…

NVST

Envista

$27.87

-1.2 (-4.13%)

DHR

Danaher

$138.78

0.1 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 07

    Nov

KALV

KalVista

$11.00

0.27 (2.52%)

, RGNX

Regenxbio

$39.53

0.65 (1.67%)

08:37
10/14/19
10/14
08:37
10/14/19
08:37
Recommendations
KalVista, Regenxbio, Kala Pharmaceuticals, Kodiak Sciences, Regeneron, Aerie Pharmaceuticals, Applied Genetic, Aldeyra, Adverum Biotechnologies, Clearside Biomedical, Ocugen analyst commentary  »

Ophthalmic therapies…

KALV

KalVista

$11.00

0.27 (2.52%)

RGNX

Regenxbio

$39.53

0.65 (1.67%)

KALA

Kala Pharmaceuticals

$3.45

-0.15 (-4.17%)

KOD

Kodiak Sciences

$18.24

1.34 (7.93%)

REGN

Regeneron

$301.02

2.56 (0.86%)

AERI

Aerie Pharmaceuticals

$20.15

2.45 (13.84%)

AGTC

Applied Genetic

$3.10

-0.08 (-2.52%)

ALDX

Aldeyra

$5.16

-0.09 (-1.71%)

ADVM

Adverum Biotechnologies

$5.29

0.11 (2.12%)

CLSD

Clearside Biomedical

$0.76

0.0326 (4.47%)

OCGN

Ocugen

$1.51

-0.07 (-4.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 24

    Oct

  • 05

    Nov

  • 06

    Nov

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:37
10/14/19
10/14
08:37
10/14/19
08:37
Hot Stocks
Parsley Energy, Jagged Peak Energy boards 'unanimously' approve merger »

The boards of directors…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

HPE

HP Enterprise

$14.35

0.24 (1.70%)

08:36
10/14/19
10/14
08:36
10/14/19
08:36
Upgrade
HP Enterprise rating change  »

HP Enterprise upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 23

    Oct

GNUS

Genius Brands

$0.77

0.0025 (0.33%)

, BABA

Alibaba

$172.97

6.925 (4.17%)

08:35
10/14/19
10/14
08:35
10/14/19
08:35
Hot Stocks
Genius Brands, Alibaba partner to co-produce animated children's series »

Genius Brands…

GNUS

Genius Brands

$0.77

0.0025 (0.33%)

BABA

Alibaba

$172.97

6.925 (4.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 19

    Nov

PE

Parsley Energy

$16.98

0.52 (3.16%)

, JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

08:35
10/14/19
10/14
08:35
10/14/19
08:35
Hot Stocks
Parsley Energy sees FY20 CapEx $1.6B-$1.9B »

Parsley (PE) remains…

PE

Parsley Energy

$16.98

0.52 (3.16%)

JAG

Jagged Peak Energy

$6.81

0.16 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CUB

Cubic

$68.86

0.58 (0.85%)

, SAIC

SAIC

$84.56

1.05 (1.26%)

08:35
10/14/19
10/14
08:35
10/14/19
08:35
Hot Stocks
Cubic appoints Hilary Hageman as general counsel »

Cubic (CUB) announced the…

CUB

Cubic

$68.86

0.58 (0.85%)

SAIC

SAIC

$84.56

1.05 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Nov

BLPH

Bellerophon

$0.45

-0.0104 (-2.26%)

08:33
10/14/19
10/14
08:33
10/14/19
08:33
Hot Stocks
Bellerophon to present new data from Cohort 1 of Phase 2/3 study of INOpulse »

lpBellerophon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PE

Parsley Energy

$16.98

0.52 (3.16%)

08:33
10/14/19
10/14
08:33
10/14/19
08:33
Hot Stocks
Parsley Energy sees Q3 net oil production 91.2-91.7 MBo per day »

For the third quarter,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

AXAS

Abraxas Petroleum

$0.37

0.0069 (1.89%)

08:33
10/14/19
10/14
08:33
10/14/19
08:33
Earnings
Abraxas Petroleum broadens engagement with Petrie Partners »

Abraxas Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

PE

Parsley Energy

$16.98

0.52 (3.16%)

08:32
10/14/19
10/14
08:32
10/14/19
08:32
Hot Stocks
Parsley Energy to acquire Jagged Peak Energy in $2.27B all-stock transaction »

Parsley Energy (PE) and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

RARE

Ultragenyx

$42.77

1.08 (2.59%)

08:31
10/14/19
10/14
08:31
10/14/19
08:31
Hot Stocks
Ultragenyx announces FDA acceptance of NDA for UX007 »

Ultragenyx Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASML

ASML

$260.46

8.86 (3.52%)

08:31
10/14/19
10/14
08:31
10/14/19
08:31
Recommendations
ASML analyst commentary  »

ASML price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.